OpenURL Connection Search

Select item for more details and to access through your institution.

Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.
Published in:
2020
By:
- Bouchacourt, B.;
- Hospital, M. A.;
- Zemmour, C.;
- Rey, J.;
- d'Incan, E.;
- Charbonnier, A.;
- Mohty, B.;
- Saillard, C.;
- Bonnet, S.;
- Collignon, A.;
- Gelsi-Boyer, V.;
- Mozziconacci, M. J.;
- Blaise, D.;
- Vey, N.
Publication type:
journal article
Azacitidine–venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
Published in:
European Journal of Haematology, 2024, v. 112, n. 4, p. 530, doi. 10.1111/ejh.14140
By:
- Petit, C.;
- Saillard, C.;
- Mohty, B.;
- Hicheri, Y.;
- Villetard, F.;
- Maisano, V.;
- Charbonnier, A.;
- Rey, J.;
- D'Incan, E.;
- Rouzaud, C.;
- Gelsi‐Boyer, V.;
- Murati, A.;
- Lhoumeau, A. C.;
- Ittel, A.;
- Mozziconacci, M. J.;
- Alary, A. S.;
- Hospital, M.‐A.;
- Vey, N.;
- Garciaz, S.
Publication type:
Article
Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT.
Published in:
Bone Marrow Transplantation, 2013, v. 48, n. 3, p. 408, doi. 10.1038/bmt.2012.167
By:
- Gerull, S;
- Stern, M;
- Ben Aissa, A;
- Manz, M G;
- Schanz, U;
- Stussi, G;
- Chalandon, Y;
- Passweg, J;
- Mohty, B
Publication type:
Article
Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 2, p. 236, doi. 10.1038/bmt.2011.57
By:
- Mohty, B;
- Thomas, Y;
- Vukicevic, M;
- Nagy, M;
- Levrat, E;
- Bernimoulin, M;
- Kaiser, L;
- Roosnek, E;
- Passweg, J;
- Chalandon, Y
Publication type:
Article
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.
Published in:
2011
By:
- Fontanet, A.;
- Chalandon, Y.;
- Roosnek, E.;
- Mohty, B.;
- Passweg, J. R.
Publication type:
Letter
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0330-5
By:
- Collignon, A.;
- Hospital, M. A.;
- Montersino, C.;
- Courtier, F.;
- Charbonnier, A.;
- Saillard, C.;
- D'Incan, E.;
- Mohty, B.;
- Guille, A.;
- Adelaïde, J.;
- Carbuccia, N.;
- Garnier, S.;
- Mozziconacci, M. J.;
- Zemmour, C.;
- Pakradouni, J.;
- Restouin, A.;
- Castellano, R.;
- Chaffanet, M.;
- Birnbaum, D.;
- Collette, Y.
Publication type:
Article
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.
Published in:
Leukemia (08876924), 2012, v. 26, n. 1, p. 73, doi. 10.1038/leu.2011.310
By:
- Mohty, B;
- El-Cheikh, J;
- Yakoub-Agha, I;
- Avet-Loiseau, H;
- Moreau, P;
- Mohty, M
Publication type:
Article
European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.
Published in:
Transplant Infectious Disease, 2013, v. 15, n. 3, p. 219, doi. 10.1111/tid.12054
By:
- Engelhard, D.;
- Mohty, B.;
- Camara, R.;
- Cordonnier, C.;
- Ljungman, P.
Publication type:
Article

Found: 8